Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

BACKGROUND: Clinical effectiveness and safety data of pazopanib in patients with advanced or mRCC in real-world setting from Asia Pacific, North Africa, and Middle East countries are lacking. METHODS: PARACHUTE is a phase IV, prospective, non-interventional, observational study. Primary endpoint was...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Erman, Bivas, Biswas, Pongwut, Danchaivijitr, Lingwu, Chen, Wong, Yoke Fui, Hashem, Tarek, Lim, Chun Sen, Karabulut, Bulent, Chung, Hsiao-Jen, Chikatapu, Chandra, Ingles, Sara, Slimane, Khemaies, Kanesvaran, Ravindran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442269/
https://www.ncbi.nlm.nih.gov/pubmed/34521387
http://dx.doi.org/10.1186/s12885-021-08738-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442269/
https://www.ncbi.nlm.nih.gov/pubmed/34521387
http://dx.doi.org/10.1186/s12885-021-08738-z

Ejemplares similares